Requests similar to 'OFI patient numbers & Costs' (page 3)

Response by Pharmaceutical Management Agency to Catherine Jamieson on January 29, 2025.

Successful.

Kia ora Catherine Thank you for your request for official information, which Pharmac received on 28 January 2025. The reference number for your reques...

AOH1996 pill

Response by Medicines Classification Committee to Chris on August 25, 2023.

Successful.

Kia ora Chris Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson ([1]she/her) | Government Se...

Trikafta Funding Announcement

Response by Pharmaceutical Management Agency to Phillip Hart on February 21, 2023.

Partially successful.

Tçnâ koe Phillip Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta...

Cost of funding Tramadol in 2019

Response by Pharmaceutical Management Agency to Brianna Stewart on August 19, 2020.

Successful.

Dear Brianna, Thank you for your request for official information, received by PHARMAC on 18 August 2020. Your request has been received a...

Has Pharmac Ever Funded A Sativex Prescritpion?

Response by Pharmaceutical Management Agency to Gregory Soar on July 24, 2015.

Successful.

Dear Mr Soar, Please find attached letter regarding your OIA request on 26 June 2015. Kind regards Alexis Poppelbaum PHARMAC 24 July 20...

COVID-19 Early Treatment Options - where are they?

Response by Pharmaceutical Management Agency to Micky Turner on December 20, 2021.

Successful.

Kia ora Micky Can I please confirm your below question still relates specifically to people with COVID-19? Ngā mihi Melody Willis (she/her) | Gover...

Pfizer Contractual Agreement

Response by Pharmaceutical Management Agency to Chuck Schooner (Account suspended) on January 19, 2022.

Long overdue.

Kia ora Chuck Please find a letter in response to your request attached with this email. Ngā mihi Melody Willis ([1]she/her) | Go...

Correspondence between Pharmac and NZMS

Response by Pharmaceutical Management Agency to D Smith on August 10, 2021.

Awaiting classification.

Kia ora D Smith Thank you for your email. Your request has been received and logged. Our reference number for your request is: 2021-22-016...

Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine

Response by Pharmaceutical Management Agency to Belinda Hodson on April 07, 2020.

Awaiting classification.

Good morning Belinda Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...

Regulatory Status and Use of “Kostaive” (Zapomeran) Vaccine in New Zealand

Response by Ministry of Health to John Armstrong on November 27, 2025.

Successful.

Kia ora John Please find attached a letter regarding your request for official information. If you wish to discuss any aspect of your re...

Vanlafaxine - Bioavailability studies

Response by Pharmaceutical Management Agency to R Whyte on April 16, 2018.

Awaiting classification.

Dear R Whyte Please see attached the response to your OIA request. Kind regards Dean Zeng PHARMAC 16 April 2018 Via Email: [e...

Ordering Moderna's Bivalent vaccine

Response by Pharmaceutical Management Agency to Athina Andonatou on September 20, 2022.

Successful.

Kia ora Athina, Thank you for your email. Your request has been received and logged as of 16 September 2022. Our reference number for your request is...

Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data

Response by Pharmaceutical Management Agency to J Bruning on August 14, 2025.

Partially successful.

Kia ora J Thank you for your request for official information, which Pharmac received on . The reference number for your request is: 2025-26-042 You...

Oestradiol (Estradot) patches, Oestradiol gel and other products

Response by Pharmaceutical Management Agency to M Williams on June 05, 2024.

Partially successful.

Kia ora, Please find a response to your Official Information Act request attached. Thank you Government Services - Pharmac 5 June 2024 M Williams V...

Legal costs in relation to proceedings: CIV-2024-404-845 – Whittome v Director-General of Health

Response by Pharmaceutical Management Agency to John Armstrong on April 24, 2026.

Refused.

Kia ora John, Thank you for your email. We have interpreted your question below as enquiring about the financial impact on Pharmac of disclosi...

Homonal treatment data

Response by Pharmaceutical Management Agency to Simon Tegg on May 06, 2024.

Successful.

Kia ora, Thank you for your request for information under the Official Information Act 1982 (OIA) request of 5 May 2024. You requested: I...

Availability and funding of WHO Essential Medicines

Response by Pharmaceutical Management Agency to Laydan Mortensen on May 19, 2015.

Information not held.

Dear Laydan Please find attached PHARMAC’s response to your recent OIA request. Kind regards Donna Donna Jennings | Communications...

Cost of Government Drug Subsidies

Response by Ministry of Health to Gregory Soar on April 11, 2015.

Successful.

Dear Gregory Please find attached PHARMAC’s response to your recent OIA request. Kind regards, Lauren Grierson PHARMAC 8 April...

Covid19 XBB Vaccine availability

Response by Pharmaceutical Management Agency to Daniel Richards on September 19, 2023.

Information not held.

Kia ora Daniel Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson ([1]she/her) | Government Se...

Medicinal Cannabis

Response by Accident Compensation Corporation to Anthony Jordan on June 19, 2023.

Awaiting classification.

Kia ora Anthony, Please find attached our response to your official information request dated 21 May 2023. If you have any questions about the resp...

Kostaive self-amplifying mRNA in New Zealand

Request to Pharmaceutical Management Agency by John Armstrong. Annotated by SPENCER JONES on January 09, 2026.

Successful.

Public Annotation – Context and Related FYI Threads (Kostaive / sa-mRNA) This request sought clarification of PHARMAC’s earlier answer regarding Kost...

Testing and Therapeutics Technical Advisory Groups documents

Response by Ministry of Health to Harold on May 23, 2022.

Successful.

Kia ora Harold Please find attached a response to your request for official information [H202204655]. Please accept our apologies for the de...

Procurement process for Cormack Draper

Response by Pharmaceutical Management Agency to Harris Leigh on March 28, 2023.

Partially successful.

Tçnâ koe Harris Please find a response to your below request for information attached to this email. Ngâ mihi, nâ Melody Willis...

ADHD and Maori/Pacific

Response by Pharmaceutical Management Agency to Rodney Parsons on October 23, 2024.

Successful.

Kia ora Rodney, Thank you for your request for official information, which Pharmac received on 22 October 2024. Our reference number for your re...

Trikafta "27 more years at full health" claim.

Response by Pharmaceutical Management Agency to Laydan Mortensen on January 24, 2025.

Successful.

Kia ora Laydan Please find attached a response to your request for official information. Ngâ mihi, Government Services | Pharmac ___________________...